Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Flyer

Health Science Journal

  • ISSN: 1791-809X
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Google Scholar citation report
Citations : 16705

Health Science Journal received 16705 citations as per Google Scholar report

Flyer image
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
View More
Share This Page

Prevalence of Chronic-Degenerative Diseases in a cohort of patients with SARSCOV2 infection

XX Congresso Regionale FADOI CAMPANIA: Non ci siamo mai fermati
Italy 2021

Asti A, Langella V, Maresca G, Pomponi D, Russo V and Di Palma G

Department of Internal Medicine, ?¢????S. Maria di Loreto Nuovo?¢??? Covid Center, Asl Napoli 1, Italy
Department of Medical Translational Sciences, University of Campania, Monaldi Hospital, Naples, Italy

Posters & Accepted Abstracts: Health Sci J

Abstract:

From March 2020 to June 2021 we admitted, in our Department, 521 patients (W=223 M=298), average age 64.8 years (SD +/- 11.4), with an average hospital stay of 24.5 days (SD +/- 7.9). Hypertension was the chronic disease with the highest prevalence (62%), treated with ARBs or ACE inhibitors (68.2% of cases), calcium channel blockers (32.7%), Beta-blockers (19, 2%), alpha-blockers (15.5%), clonidine (4.4%). The prevalence of COPD was 20.7% and was treated by inhalation with triple combination (74.8% of cases), with cortisone + beta stimulant (15.3%) or with anticholinergics (9.9%). Type 2 diabetes mellitus had a prevalence of 16.7% and we preferred to treat it with a basalbolus insulin scheme, in the absence of studies on the use of oral hypoglycemic agents in patients with SARS-COV2 infection. Previous ischemic heart disease had a prevalence of 21.9%, permanent atrial fibrillation of 12.4% (treated with NAO in 85.1% of cases), chronic renal failure of 10%, obesity (higher BMI a 30) by 10.6%, chronic liver disease by 4.2%, chronic thyroid disease by 14.5% (hypothyroidism 86.6%). The prevalence of a history of malignancy was 8.1%. Finally, smokers were 20.5%, higher prevalence in men (72,4%) (current smokers 6.4% of all patients).

PDF HTML